JP2010063441A - Methods for removing fat and treating living tissue - Google Patents

Methods for removing fat and treating living tissue Download PDF

Info

Publication number
JP2010063441A
JP2010063441A JP2008235634A JP2008235634A JP2010063441A JP 2010063441 A JP2010063441 A JP 2010063441A JP 2008235634 A JP2008235634 A JP 2008235634A JP 2008235634 A JP2008235634 A JP 2008235634A JP 2010063441 A JP2010063441 A JP 2010063441A
Authority
JP
Japan
Prior art keywords
emulsion
cell suspension
fat
surfactant
biological tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2008235634A
Other languages
Japanese (ja)
Inventor
Tomoaki Tamura
知明 田村
Koka Rin
孔華 林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Olympus Corp
Original Assignee
Olympus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Olympus Corp filed Critical Olympus Corp
Priority to JP2008235634A priority Critical patent/JP2010063441A/en
Publication of JP2010063441A publication Critical patent/JP2010063441A/en
Withdrawn legal-status Critical Current

Links

Images

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide methods for removing fat and treating a living tissue wherein the fat is efficiently removed from living tissue-derived cells that are collected from a cell suspension obtained by decomposing the living tissue. <P>SOLUTION: There is provided a method for removing fat comprising: a vessel-treating step S21 in which a surfactant solution 8 containing a surfactant 7 is brought into contact with an inner wall 6a of a condensation vessel 6 storing a cell suspension 3 obtained by decomposing the living tissue 1; emulsion-forming step S22 in which a cell suspension 3 is stirred in the condensation vessel 6; and an emulsion-removing step S23 in which an emulsion formed in the emulsion-forming step S22 is removed. <P>COPYRIGHT: (C)2010,JPO&INPIT

Description

本発明は、脂肪除去方法および生体組織処理方法に関するものである。   The present invention relates to a fat removal method and a biological tissue processing method.

従来、生体組織由来の細胞を得るには、生体組織を消化酵素液で分解して、生体組織から分離した細胞を含む細胞懸濁液とし、細胞懸濁液を洗浄、濃縮して所望の細胞の細胞濃縮液を生成する(例えば、特許文献1参照。)。生体組織から分離した細胞を再生医療などに用いる場合、最終生成物である細胞濃縮液に組織由来の脂肪が残留すると治療効果に影響を及ぼす可能性があるため、脂肪を含まない高純度な細胞濃縮液が求められる。   Conventionally, in order to obtain cells derived from living tissue, the living tissue is decomposed with a digestive enzyme solution to obtain a cell suspension containing cells separated from the living tissue, and the cell suspension is washed and concentrated to obtain desired cells. Cell concentrate (see, for example, Patent Document 1). When cells separated from living tissue are used for regenerative medicine, etc., if fat derived from tissue remains in the cell concentrate that is the final product, it may affect the therapeutic effect, so high purity cells that do not contain fat A concentrate is required.

一方、昆虫細胞をバイオリアクター内で昆虫細胞を攪拌する際に界面活性剤であるプルロニックF68を添加すると、プルロニックF68の保護効果により昆虫細胞は損傷を受けることなく正常に成長できるということが報告されている(非特許文献1参照。)。   On the other hand, it has been reported that when pluronic F68, a surfactant, is added when stirring insect cells in a bioreactor, insect cells can grow normally without being damaged due to the protective effect of pluronic F68. (See Non-Patent Document 1).

国際公開第05/012480号パンフレットWO05 / 012480 pamphlet David W. Murhammer & Charles F. Goochee,“Scaleup of Insect Cell Cultures: Protective Effects of Pluronic F-68”,Bio/Technology, 6, 1998, p.1411-p.1418David W. Murhammer & Charles F. Goochee, “Scaleup of Insect Cell Cultures: Protective Effects of Pluronic F-68”, Bio / Technology, 6, 1998, p.1411-p.1418

しかしながら、細胞懸濁液に含まれる脂肪が容器の内壁に吸着しやすく、遠心分離後に細胞濃縮液を回収する際に内壁に吸着した脂肪も同時に回収してしまい、脂肪を含まない高純度の細胞液を得るのは困難である。
容器の内壁へ脂肪が吸着するのを防ぐために、内壁の表面に微細な凹凸構造を施すまたは表面をテフロンなどでコートする表面処理も考えられるが、コストの高騰や滅菌処理に弱いという問題があり実用的でない。現段階では、効率よく脂肪を除去するために上清に浮く脂肪を取り除く以外の工夫はなく、脂肪除去に時間と労力がかかるという不都合がある。
However, the fat contained in the cell suspension tends to be adsorbed on the inner wall of the container, and when the cell concentrate is collected after centrifugation, the fat adsorbed on the inner wall is also collected at the same time. It is difficult to obtain a liquid.
In order to prevent fat from adsorbing to the inner wall of the container, a surface treatment in which a fine uneven structure is applied to the surface of the inner wall or the surface is coated with Teflon, etc., can be considered, but there are problems that the cost is high and sterilization is weak Not practical. At the present stage, there is no ingenuity other than removing fat floating in the supernatant in order to efficiently remove fat, and there is a disadvantage that it takes time and labor to remove fat.

本発明は上述した事情に鑑みてなされたものであって、生体組織を分解して得られた細胞懸濁液から採取する生体組織由来細胞から効率的に脂肪を除去する脂肪除去方法および生体組織処理方法を提供することを目的としている。   The present invention has been made in view of the circumstances described above, and a fat removal method and biological tissue for efficiently removing fat from biological tissue-derived cells collected from a cell suspension obtained by decomposing biological tissue. It aims to provide a processing method.

上記目的を達成するために、本発明は以下の手段を提供する。
本発明は、生体組織を分解して得られた細胞懸濁液を収容する濃縮容器の内壁に界面活性剤を含む界面活性溶液を接触させる容器処理ステップと、前記濃縮容器内で前記細胞懸濁液を攪拌するエマルション形成ステップと、該エマルション形成ステップにおいて形成されるエマルションを除去するエマルション除去ステップとを備える脂肪除去方法を提供する。
In order to achieve the above object, the present invention provides the following means.
The present invention includes a container processing step in which a surfactant solution containing a surfactant is brought into contact with an inner wall of a concentration container that contains a cell suspension obtained by decomposing a biological tissue, and the cell suspension in the concentration container There is provided a fat removing method comprising an emulsion forming step of stirring a liquid and an emulsion removing step of removing the emulsion formed in the emulsion forming step.

本発明によれば、濃縮容器に細胞懸濁液を収容する前に予め容器処理ステップにおいて、濃縮容器の内壁に界面活性剤を含む界面活性溶液を接触させ、内壁を界面活性溶液で濡らしておく。疎水性の濃縮容器内面は、界面活性剤が疎水性側を濃縮容器の内壁側へ、親水性側を濃縮容器の半径方向内方へ向けて並んだ界面活性剤層で覆われ親水性となる。また、界面活性溶液の水滴が内壁に付着した状態ができる。この後に濃縮容器内に細胞懸濁液を収容し、エマルション形成ステップにより細胞懸濁液を攪拌すると、水滴に含まれる界面活性剤により、細胞懸濁液に含まれる脂肪分はミセルを形成し、このミセルが細胞懸濁液内に分散してエマルションを形成する。また、細胞懸濁液内に含まれる脂肪分は疎水性を有するため、親水性の濃縮容器内壁へ吸着しない。   According to the present invention, before storing the cell suspension in the concentration container, in the container processing step, the inner surface of the concentration container is contacted with the surfactant solution containing the surfactant, and the inner wall is wetted with the surfactant solution. . The inner surface of the hydrophobic concentration container is hydrophilic because the surfactant is covered with a surfactant layer arranged with the hydrophobic side facing the inner wall of the concentration container and the hydrophilic side facing the inner side in the radial direction of the concentration container. . Moreover, the state which the water droplet of surface active solution adhered to the inner wall is made. After this, the cell suspension is accommodated in a concentration container, and when the cell suspension is stirred by the emulsion formation step, the fat contained in the cell suspension forms micelles by the surfactant contained in the water droplets. These micelles are dispersed in the cell suspension to form an emulsion. Further, since the fat contained in the cell suspension has hydrophobicity, it is not adsorbed on the inner wall of the hydrophilic concentration container.

したがって、エマルション除去ステップにおいて細胞懸濁液からエマルション形成した溶液を除去すると、同時にミセル状の脂肪分も除去される。この場合に、エマルション形成した溶液は濃縮容器内壁に吸着し難いので、濃縮容器内壁に脂肪分が吸着して残留することなく、効率的に脂肪分を濃縮容器内から除去することができる。   Therefore, when the emulsion-formed solution is removed from the cell suspension in the emulsion removal step, the micellar fat is also removed at the same time. In this case, since the emulsion-formed solution is difficult to be adsorbed on the inner wall of the concentration container, the fat can be efficiently removed from the concentration container without adsorbing and remaining on the inner wall of the concentration container.

また、上記発明においては、前記界面活性溶液が、洗浄液であってもよい。
このようにすることで、界面活性剤を含む洗浄液で濃縮容器内部をすすぐと、濃縮容器内壁が界面活性剤の層で覆われ、濡れた状態をつくることができ、簡易な方法で容器処理ステップを行うことができる。
In the above invention, the surfactant solution may be a cleaning solution.
In this way, when the inside of the concentration container is rinsed with a cleaning solution containing a surfactant, the inner wall of the concentration container is covered with a layer of surfactant, and a wet state can be created. It can be performed.

また、上記発明においては、前記界面活性剤が、2−メタクロイルオキシホスホリルコリン(MPC、日本油脂社製)またはプルロニックF68(ADEKA社製)またはパーフルオロカーボンエマルションであることが好ましい。
MPCまたはプルロニックF68またはパーフルオロカーボンエマルションは、生体安全性が確かめられているため、最終生成物に残留しても問題にならない。また、プルロニックF68は攪拌による細胞への損傷を軽減する効果があることがわかっている。
In the above invention, the surfactant is preferably 2-methacryloyloxyphosphorylcholine (MPC, manufactured by NOF Corporation), Pluronic F68 (produced by ADEKA Corporation), or a perfluorocarbon emulsion.
Since MPC or Pluronic F68 or perfluorocarbon emulsion has been confirmed to be biosafety, it does not matter if it remains in the final product. In addition, it has been found that Pluronic F68 has an effect of reducing damage to cells caused by stirring.

また、上記発明においては、前記エマルション形成ステップが、5〜400rpmで前記細胞懸濁液を攪拌することが望ましい。
5〜400rpmで細胞懸濁液を攪拌することで、気泡の発生を抑えながら効率よくエマルションを形成させ、また、細胞の損傷を軽減することができる。
Moreover, in the said invention, it is desirable that the said emulsion formation step stirs the said cell suspension at 5-400 rpm.
By stirring the cell suspension at 5 to 400 rpm, it is possible to efficiently form an emulsion while suppressing the generation of bubbles, and to reduce cell damage.

また、本発明は、生体組織を消化酵素溶液で分解し細胞懸濁液を得る組織分解ステップと、前記細胞懸濁液から脂肪分を除去する脂肪除去ステップと、該脂肪除去ステップで得られた生体組織由来細胞を洗浄し濃縮する細胞洗浄ステップとを備え、前記脂肪除去ステップが、前記細胞懸濁液を収容する濃縮容器の内壁に界面活性剤を含む界面活性溶液を接触させる容器処理ステップと、前記濃縮容器内で前記細胞懸濁液を攪拌するエマルション形成ステップと、該エマルション形成ステップにおいて形成されたエマルションを除去するエマルション除去ステップとを備える生体組織処理方法を提供する。   Further, the present invention is obtained by a tissue degradation step of degrading a living tissue with a digestive enzyme solution to obtain a cell suspension, a fat removal step of removing fat from the cell suspension, and the fat removal step A cell washing step for washing and concentrating cells derived from biological tissue, wherein the fat removal step comprises contacting a surfactant solution containing a surfactant with an inner wall of a concentration vessel containing the cell suspension; There is provided a biological tissue treatment method comprising an emulsion forming step of stirring the cell suspension in the concentration container, and an emulsion removing step of removing the emulsion formed in the emulsion forming step.

本発明によれば、組織分解ステップにおいて生体組織を消化酵素を含む消化酵素溶液内で攪拌して生体組織を分解すると、生体組織から生体組織由来細胞が分離し細胞懸濁液を得る。細胞懸濁液内には生体組織由来の脂肪分が含まれるため、脂肪除去ステップにおいて細胞懸濁液から脂肪分を除去し、脂肪分をほとんど含まない生体組織由来細胞の細胞濃縮液を得る。そして、細胞洗浄ステップにおいて、脂肪除去ステップで得られた細胞濃縮液を洗浄液内で攪拌した後遠心分離で生体組織由来細胞の沈殿と不純物が混入した上清に分離し、上清を除去することで、最終生成物である洗浄された生体組織由来細胞の細胞濃縮液を得ることができる。   According to the present invention, when a biological tissue is agitated in a digestive enzyme solution containing a digestive enzyme in the tissue decomposition step to decompose the biological tissue, the biological tissue-derived cells are separated from the biological tissue to obtain a cell suspension. Since the fat content derived from living tissue is contained in the cell suspension, the fat content is removed from the cell suspension in the fat removal step to obtain a cell concentrate of living tissue-derived cells containing almost no fat content. In the cell washing step, the cell concentrate obtained in the fat removal step is stirred in the washing solution, and then separated into a supernatant mixed with precipitates and impurities of biological tissue-derived cells by centrifugation, and the supernatant is removed. Thus, a cell concentrate of washed biological tissue-derived cells, which is the final product, can be obtained.

この場合に、脂肪除去ステップにおいて、組織分解ステップで得られる細胞懸濁液を濃縮容器に収容する前に、予め容器処理ステップを行い濃縮容器の内壁を界面活性剤を含む界面活性液に接触させておく。これにより、エマルション形成ステップにおいて細胞懸濁液を攪拌したときに脂肪分がミセルを形成し、このミセルが細胞懸濁液内に分散してエマルションを形成するので、エマルション除去ステップにおいて溶液と同時に脂肪分も除去できる。また、その際に濃縮容器内壁に脂肪分が吸着して残留することがないので、効率的に脂肪分を除去することができる。   In this case, in the fat removal step, before the cell suspension obtained in the tissue decomposition step is accommodated in the concentration container, the container treatment step is performed in advance so that the inner wall of the concentration container is brought into contact with the surfactant-containing surfactant. Keep it. Thus, when the cell suspension is agitated in the emulsion formation step, the fat content forms micelles, and these micelles are dispersed in the cell suspension to form an emulsion. Minutes can be removed. Further, at this time, the fat is not adsorbed and remains on the inner wall of the concentration container, so that the fat can be efficiently removed.

続く細胞洗浄ステップにおいても、細胞濃縮液内に残留した脂肪分は残留した界面活性剤によりミセル状になって洗浄液内に分散するので、洗浄液と同時に残留した脂肪分も除去できる。また、容器処理ステップにおいて界面活性剤層に覆われた濃縮容器の内壁は親水性が保たれるので、洗浄液を除去する際に脂肪分が内壁に吸着することを防ぐことができる。その結果、洗浄液を排出し濃縮容器内に残った生体組織由来細胞の細胞濃縮液を回収する際に同時に脂肪を回収してしまうという不都合がなく、最終生成物として純度の高い生体組織由来細胞を得ることができる。   Also in the subsequent cell washing step, the fat remaining in the cell concentrate becomes micelle by the remaining surfactant and is dispersed in the washing liquid, so that the fat remaining simultaneously with the washing liquid can also be removed. Further, since the inner wall of the concentration container covered with the surfactant layer in the container processing step is kept hydrophilic, it is possible to prevent fat from being adsorbed on the inner wall when removing the cleaning liquid. As a result, there is no inconvenience of collecting fat at the same time when the washing liquid is discharged and the cell concentrate of the living tissue-derived cells remaining in the concentration container is recovered, and high-quality living tissue-derived cells are used as the final product. Obtainable.

上記発明においては、前記容器処理ステップの後に、該容器処理ステップにおいて内壁に界面活性溶液を接触させた濃縮容器内において、組織分解ステップを行ってもよい。
このようにすることで、内壁表面が界面活性剤層に覆われ親水性になり、界面活性溶液の水滴が付着した状態の濃縮容器内で組織分解ステップを行うと、生体組織を分解しながら、生体組織から分離した脂肪をミセル状にして消化解酵素液内へ分散させエマルションを形成させることができる。
In the above invention, after the container processing step, a tissue decomposition step may be performed in a concentration container in which the surface active solution is brought into contact with the inner wall in the container processing step.
By doing in this way, when the inner wall surface is covered with the surfactant layer and becomes hydrophilic, and the tissue decomposition step is performed in the concentration container with the water droplets of the surface active solution attached, the biological tissue is decomposed, The fat separated from the living tissue can be micellar and dispersed in the digestive enzyme solution to form an emulsion.

すなわち、組織分解ステップとエマルション形成ステップを同時に行うことができるので作業の効率が上がる。また、組織分解ステップとエマルション形成ステップでそれぞれ行っていた攪拌を1回に減らすことができるので、攪拌による細胞への損傷を軽減することができる。   That is, since the tissue decomposition step and the emulsion formation step can be performed at the same time, the work efficiency increases. Moreover, since the agitation performed in each of the tissue degradation step and the emulsion formation step can be reduced to one time, damage to cells due to agitation can be reduced.

また、上記発明においては、前記界面活性溶液が、洗浄液であってもよい。
また、上記発明においては、前記界面活性剤が、MPCまたはプルロニックF68またはパーフルオロカーボンエマルションであることが好ましい。
また、上記発明においては、前記エマルション形成ステップが、5〜400rpmで細胞懸濁液を攪拌することが好ましい。
In the above invention, the surfactant solution may be a cleaning solution.
Moreover, in the said invention, it is preferable that the said surfactant is MPC, pluronic F68, or a perfluorocarbon emulsion.
Moreover, in the said invention, it is preferable that the said emulsion formation step stirs a cell suspension at 5-400 rpm.

本発明によれば、生体組織を分解して得られた細胞懸濁液から採取する生体組織由来細胞から効率的に脂肪を除去することができるという効果を奏する。   According to the present invention, there is an effect that fat can be efficiently removed from living tissue-derived cells collected from a cell suspension obtained by decomposing living tissue.

本発明の一実施形態に係る脂肪除去方法および生体組織処理方法について、図1を参照して以下に説明する。
本実施形態に係る生体組織の処理方法は、図1に示されるように、生体組織1を消化酵素溶液2で分解して細胞懸濁液3を得る組織分解ステップS1と、組織分解ステップS1で得た細胞懸濁液3から生体組織1由来の脂肪分4を除去する脂肪除去ステップS2と、脂肪分4を除去した生体組織由来細胞5を洗浄し濃縮する細胞洗浄ステップS3とを備えている。
本実施形態に係る脂肪除去方法は、上記脂肪除去ステップS2である。
A fat removal method and a biological tissue processing method according to an embodiment of the present invention will be described below with reference to FIG.
As shown in FIG. 1, the biological tissue processing method according to this embodiment includes a tissue decomposition step S1 in which a biological tissue 1 is decomposed with a digestive enzyme solution 2 to obtain a cell suspension 3, and a tissue decomposition step S1. A fat removing step S2 for removing the fat 4 derived from the living tissue 1 from the obtained cell suspension 3 and a cell washing step S3 for washing and concentrating the living tissue-derived cells 5 from which the fat 4 has been removed are provided. .
The fat removal method according to the present embodiment is the fat removal step S2.

脂肪分解ステップS1は、生体組織1を消化酵素溶液2内で攪拌することにより行われる。消化酵素により生体組織1が分解されると生体組織1から生体組織由来細胞5が分離し、消化酵素溶液2内に生体組織由来細胞5が浮遊する細胞懸濁液3が得られる。   The lipolysis step S1 is performed by stirring the living tissue 1 in the digestive enzyme solution 2. When the biological tissue 1 is decomposed by the digestive enzyme, the biological tissue-derived cells 5 are separated from the biological tissue 1, and a cell suspension 3 in which the biological tissue-derived cells 5 float in the digestive enzyme solution 2 is obtained.

脂肪除去ステップS2は、濃縮容器6の内壁6aを界面活性剤7を含む界面活性溶液8に接触させる容器処理ステップS21と、界面活性溶液8に接触させた濃縮容器6内で細胞懸濁液3を攪拌しエマルションを形成させるエマルション形成ステップS22と、エマルション形成ステップS22で形成したエマルションを除去するエマルション除去ステップS23とを備えている。   The fat removal step S2 includes a container processing step S21 in which the inner wall 6a of the concentration container 6 is brought into contact with the surfactant solution 8 containing the surfactant 7, and the cell suspension 3 in the concentration container 6 in contact with the surfactant solution 8. Are formed, and an emulsion formation step S22 for forming an emulsion and an emulsion removal step S23 for removing the emulsion formed in the emulsion formation step S22 are provided.

容器処理ステップS21は、例えば、洗浄液9である乳酸リンゲル液(以下LR液)に1%の界面活性剤7であるプルロニックF68を添加した1%プルロニックF68/LR液(界面活性溶液8)で濃縮容器6内部をすすぐことにより行われる。これにより、疎水性の濃縮容器6の内壁6aは、プルロニックF68が疎水性側を濃縮容器6の内壁6a側へ、親水性側を濃縮容器6の半径方向内方へ向けて並んだプルロニックF68の層に覆われ親水性になる。   The container processing step S21 is, for example, a 1% pluronic F68 / LR solution (surfactant solution 8) that is a 1% pluronic F68 / LR solution obtained by adding 1% surfactant pluronic F68 to a lactic acid Ringer solution (hereinafter referred to as LR solution) that is a cleaning solution 9. 6 by rinsing the interior. As a result, the inner wall 6a of the hydrophobic concentration container 6 has the pluronic F68 lined up with the pluronic F68 aligned with the hydrophobic side toward the inner wall 6a side of the concentration container 6 and the hydrophilic side toward the radially inner side of the concentration container 6. It is covered with a layer and becomes hydrophilic.

また、内壁6aは、1%プルロニックF68/LR液の水滴が付着した状態になる。エマルション形成ステップS22は、このような濃縮容器6に組織分解ステップS1で得た細胞懸濁液3を収容し5〜400rpmで攪拌することにより行われる。細胞懸濁液3に含まれる生体組織1由来の脂肪分4が濃縮容器6の内壁6aに付着したプルロニックF68によりミセル状になり細胞懸濁液3内へ分散されエマルションを形成する。   Further, the inner wall 6a is in a state where water droplets of 1% pluronic F68 / LR liquid are attached. The emulsion formation step S22 is performed by storing the cell suspension 3 obtained in the tissue decomposition step S1 in such a concentration container 6 and stirring at 5 to 400 rpm. The fat 4 derived from the living tissue 1 contained in the cell suspension 3 becomes micelles by the Pluronic F68 attached to the inner wall 6a of the concentration container 6, and is dispersed into the cell suspension 3 to form an emulsion.

続いて、エマルション除去ステップS23により濃縮容器6を遠心分離し、生体組織由来細胞5を含む沈殿とエマルションを形成した上清とに分離する。そして上清を除去すると、同時に上清内にミセル状で分散する脂肪分4も除去され、沈殿した脂肪分4をほとんど含まない生体組織由来細胞5の細胞濃縮液が濃縮容器6内に残る。   Then, the concentration container 6 is centrifuged by emulsion removal step S23, and it isolate | separates into the sediment containing the biological tissue origin cell 5 and the supernatant which formed the emulsion. When the supernatant is removed, the fat 4 dispersed in a micelle form in the supernatant is also removed, and a cell concentrate of the biological tissue-derived cells 5 containing almost no precipitated fat 4 remains in the concentration container 6.

細胞洗浄ステップS3は、エマルション除去ステップS23で得られた細胞濃縮液が残った濃縮容器6に洗浄液9、例えば、LR液を注入して攪拌し、遠心分離により生体組織由来細胞5の沈殿とLR液の上清に分離し上清を除去することにより行われる。細胞濃縮液に残留する脂肪分4は、細胞濃縮液に残留したプルロニックF68によりミセルを形成してLR液内に分散され、LR液とともに排出されるようになっている。   In the cell washing step S3, the washing solution 9, for example, LR solution, is injected into the concentration vessel 6 in which the cell concentrate obtained in the emulsion removal step S23 remains, and the mixture is stirred and centrifuged. It is carried out by separating into a supernatant of the liquid and removing the supernatant. Fat 4 remaining in the cell concentrate forms micelles by pluronic F68 remaining in the cell concentrate, is dispersed in the LR solution, and is discharged together with the LR solution.

脂肪分4以外の残留する不純物も攪拌によりLR液内に分散されLR液とともに排出される。この細胞洗浄ステップS3を1回以上繰り返すことで、細胞濃縮液に残留する不純物を除去し、最終生成物である生体組織由来細胞5の細胞濃縮液を得る。   The remaining impurities other than fat 4 are also dispersed in the LR liquid by stirring and discharged together with the LR liquid. By repeating this cell washing step S3 one or more times, impurities remaining in the cell concentrate are removed, and a cell concentrate of the biological tissue-derived cells 5 as the final product is obtained.

この場合に、容器処理ステップS21においてプルロニックF68の層に覆われた濃縮容器6の内壁6aは親水性を保っているので、LR液を排出する際に細胞濃縮液に残留した脂肪分4が内壁6aに吸着しないようになっている。その結果、LR液で洗浄した最終生成物である生体組織由来細胞5の細胞濃縮液を濃縮容器6から回収する際に、濃縮容器6の内壁6aに吸着した脂肪分4を同時に回収してしまうという不都合を回避でき、脂肪分4を含まない純度の高い生体組織由来細胞5の細胞濃縮液を得ることができるという利点がある。   In this case, since the inner wall 6a of the concentration container 6 covered with the layer of Pluronic F68 in the container processing step S21 is kept hydrophilic, the fat 4 remaining in the cell concentrate is discharged from the inner wall when the LR solution is discharged. 6a is not adsorbed. As a result, when the cell concentrate of the biological tissue-derived cells 5 that is the final product washed with the LR solution is recovered from the concentration container 6, the fat 4 adsorbed on the inner wall 6a of the concentration container 6 is simultaneously recovered. There is an advantage that a cell concentrate of the biological tissue-derived cell 5 having a high purity and free from fat 4 can be obtained.

このように、本実施形態に係る脂肪除去方法および生体組織処理方法によれば、濃縮容器6の内部をプルロニックF68/LR液で洗浄するだけで、濃縮容器6内に収容する細胞懸濁液3内に生体組織1由来の脂肪分4を分散しエマルションを形成させるとともに脂肪分4の濃縮容器6の内壁6aへの吸着を防ぐことができる。その結果、効率的に生体組織由来細胞5から脂肪分4を除去し、生体組織1の処理にかかる時間と労力と軽減することができる。   As described above, according to the fat removal method and the biological tissue processing method according to the present embodiment, the cell suspension 3 accommodated in the concentration container 6 simply by washing the inside of the concentration container 6 with the pluronic F68 / LR solution. The fat 4 derived from the living tissue 1 can be dispersed therein to form an emulsion, and the fat 4 can be prevented from adsorbing to the inner wall 6a of the concentration container 6. As a result, the fat content 4 can be efficiently removed from the living tissue-derived cells 5, and the time and labor required for the processing of the living tissue 1 can be reduced.

なお、本実施形態においては、前記容器処理ステップS21の後に、該容器処理ステップS21において濃縮容器6の内壁6aに界面活性溶液8を接触させた濃縮容器6内において前記組織分解ステップS1を行ってもよい。   In the present embodiment, after the container processing step S21, the tissue decomposition step S1 is performed in the concentration container 6 in which the surface active solution 8 is brought into contact with the inner wall 6a of the concentration container 6 in the container processing step S21. Also good.

容器処理ステップS21において濃縮容器6の内壁6aがプルロニックF68層に覆われ親水性になり、プルロニックF68/LR液の水滴が付着した状態を作った濃縮容器6内に生体組織1と消化酵素溶液2を収容し、攪拌して生体組織1を分解する。このようにすることで、生体組織1を分解する工程と、生体組織1に含まれる脂肪分4がミセル状になって消化酵素溶液2内へ分散しエマルションを形成する工程を同時に行うことができ、作業の効率を上げることができる。また、攪拌の工程を減らすことができるので生体組織由来細胞5の損傷を軽減できる。   In the container processing step S21, the inner wall 6a of the concentration container 6 is covered with the Pluronic F68 layer and becomes hydrophilic, and the living tissue 1 and the digestive enzyme solution 2 are formed in the concentration container 6 in which water droplets of the Pluronic F68 / LR liquid are attached. And the biological tissue 1 is decomposed by stirring. By doing in this way, the process of decomposing | disassembling the biological tissue 1 and the process which the fat part 4 contained in the biological tissue 1 becomes a micelle form, and it disperse | distributes in the digestive enzyme solution 2, and can form an emulsion can be performed simultaneously. , Can increase the efficiency of work. Moreover, since the stirring process can be reduced, damage to the living tissue-derived cells 5 can be reduced.

また、本実施形態においては、界面活性剤7としてプルロニックF68を用いることとしたが、これに代えて、MPCまたはパーフルオロカーボンエマルションを用いてもよい。
プルロニックF68またはMPCまたはパーフルオロカーボンエマルションは生体安全性が確かめられており、最終生成物に残留しても生体への安全性に問題がない。
In the present embodiment, Pluronic F68 is used as the surfactant 7, but MPC or perfluorocarbon emulsion may be used instead.
Pluronic F68 or MPC or perfluorocarbon emulsion has been confirmed to be biosafety, and even if it remains in the final product, there is no problem with safety to the living body.

また、本実施形態においては、エマルション形成ステップS22において細胞懸濁液3を5〜400rpmで攪拌することとしたが、30〜100rpmで攪拌することが望ましい。このようにすることで、効率よくエマルションを形成させながら細胞懸濁液3内の生体組織由来細胞5への損傷を軽減することができる。   In the present embodiment, the cell suspension 3 is stirred at 5 to 400 rpm in the emulsion forming step S22, but it is desirable to stir at 30 to 100 rpm. By doing in this way, the damage to the biological tissue origin cell 5 in the cell suspension 3 can be reduced, forming an emulsion efficiently.

また、本実施形態においては、エマルション除去ステップS23において前記濃縮容器6を遠心分離することにより生体組織由来細胞5の沈殿とエマルションの上清に分離し上清を除去することしたが、これに代えて、フィルターにより濃縮容器6内からエマルションを除去してもよい。   Moreover, in this embodiment, in the emulsion removal step S23, the concentration container 6 is centrifuged to separate the biological tissue-derived cell 5 from the precipitate and the emulsion supernatant, and the supernatant is removed. The emulsion may be removed from the concentration container 6 by a filter.

また、本実施形態においては、容器処理ステップS21において1%プルロニックF68/LR溶液を注入することとしたが、これに代えて、プルロニックF68とLR液を独立に注入して濃縮容器6内で1%プルロニックF68/LR液を調製してもよい   In the present embodiment, the 1% pluronic F68 / LR solution is injected in the container processing step S21. Instead of this, the pluronic F68 and the LR solution are independently injected, and 1 in the concentration container 6 is injected. % Pluronic F68 / LR solution may be prepared

また、本実施形態においては、プルロニックF68により生体組織1由来の脂肪分4がミセル状になりエマルションを形成すれば、該エマルションを分離しなくてもよい。
エマルションを栄養として動脈投入し利用することができる。
Moreover, in this embodiment, if the fat 4 derived from the biological tissue 1 becomes a micelle shape and forms an emulsion by Pluronic F68, the emulsion does not need to be separated.
Emulsions can be used as nutrients in the arteries.

本発明の一実施形態に係る脂肪除去方法および生体組織処理方法の手順を示す概念図である。It is a conceptual diagram which shows the procedure of the fat removal method and biological tissue processing method which concern on one Embodiment of this invention.

符号の説明Explanation of symbols

1 生体組織
2 消化酵素溶液
3 細胞懸濁液
4 脂肪分
5 生体組織由来細胞
6 濃縮容器
6a 内壁
7 界面活性剤
8 界面活性溶液
9 洗浄液
S1 組織分解ステップ
S2 脂肪除去ステップ
S21 容器処理ステップ
S22 エマルション形成ステップ
S23 エマルション除去ステップ
S3 細胞洗浄ステップ
DESCRIPTION OF SYMBOLS 1 Living tissue 2 Digestive enzyme solution 3 Cell suspension 4 Fat content 5 Living tissue origin cell 6 Concentration container 6a Inner wall 7 Surfactant 8 Surfactant 9 Washing solution S1 Tissue decomposition step S2 Fat removal step S21 Container processing step S22 Emulsion formation Step S23 Emulsion removal step S3 Cell washing step

Claims (9)

生体組織を分解して得られた細胞懸濁液を収容する濃縮容器の内壁に界面活性剤を含む界面活性溶液を接触させる容器処理ステップと、
前記濃縮容器内で前記細胞懸濁液を攪拌するエマルション形成ステップと、
該エマルション形成ステップにおいて形成されたエマルションを除去するエマルション除去ステップとを備える脂肪除去方法。
A container treatment step in which a surfactant solution containing a surfactant is brought into contact with an inner wall of a concentration container containing a cell suspension obtained by decomposing a biological tissue;
An emulsion forming step of stirring the cell suspension in the concentration vessel;
A fat removal method comprising: an emulsion removal step of removing the emulsion formed in the emulsion formation step.
前記界面活性溶液が、洗浄液である請求項1に記載の脂肪除去方法。   The fat removal method according to claim 1, wherein the surfactant solution is a cleaning solution. 前記界面活性剤が、MPCまたはプルロニックF68またはパーフルオロカーボンエマルションである請求項1または請求項2に記載の脂肪除去方法。   The fat removal method according to claim 1 or 2, wherein the surfactant is MPC, Pluronic F68, or perfluorocarbon emulsion. 前記エマルション形成ステップが、5〜400rpmで前記細胞懸濁液を攪拌する請求項1から請求項3のいずれかに記載の脂肪除去方法。   The fat removal method according to any one of claims 1 to 3, wherein the emulsion forming step stirs the cell suspension at 5 to 400 rpm. 生体組織を消化酵素溶液で分解し細胞懸濁液を得る組織分解ステップと、
前記細胞懸濁液から脂肪分を除去する脂肪除去ステップと、
該脂肪除去ステップで得られた生体組織由来細胞を洗浄し濃縮する細胞洗浄ステップとを備え、
前記脂肪除去ステップが、
前記細胞懸濁液を収容する濃縮容器の内壁に界面活性剤を含む界面活性溶液を接触させる容器処理ステップと、
前記濃縮容器内で前記細胞懸濁液を攪拌するエマルション形成ステップと、
該エマルション形成ステップにおいて形成されたエマルションを除去するエマルション除去ステップとを備える生体組織処理方法。
A tissue degradation step of degrading a biological tissue with a digestive enzyme solution to obtain a cell suspension;
Removing fat from the cell suspension; and
A cell washing step of washing and concentrating cells derived from the biological tissue obtained in the fat removal step,
The fat removal step comprises:
A container treatment step in which a surfactant solution containing a surfactant is brought into contact with an inner wall of a concentration container containing the cell suspension; and
An emulsion forming step of stirring the cell suspension in the concentration vessel;
A biological tissue treatment method comprising: an emulsion removal step of removing the emulsion formed in the emulsion formation step.
前記容器処理ステップの後に、該容器処理ステップにおいて内壁に界面活性溶液を接触させた濃縮容器内において前記組織分解ステップを行う請求項5に記載の生体組織処理方法。   The biological tissue processing method according to claim 5, wherein after the container processing step, the tissue decomposition step is performed in a concentration container in which a surface-active solution is brought into contact with an inner wall in the container processing step. 前記界面活性溶液が、洗浄液である請求項5または請求項6に記載の生体組織処理方法。   The biological tissue treatment method according to claim 5 or 6, wherein the surface-active solution is a cleaning liquid. 前記界面活性剤が、MPCまたはプルロニックF68またはパーフルオロカーボンエマルションである請求項5から請求項7のいずれかに記載の生体組織処理方法。   The biological tissue treatment method according to any one of claims 5 to 7, wherein the surfactant is MPC, pluronic F68, or perfluorocarbon emulsion. 前記エマルション形成ステップが、5〜400rpmで前記細胞懸濁液を攪拌する請求項5から請求項8のいずれかに記載の生体組織処理方法。   The biological tissue treatment method according to any one of claims 5 to 8, wherein the emulsion forming step stirs the cell suspension at 5 to 400 rpm.
JP2008235634A 2008-09-12 2008-09-12 Methods for removing fat and treating living tissue Withdrawn JP2010063441A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2008235634A JP2010063441A (en) 2008-09-12 2008-09-12 Methods for removing fat and treating living tissue

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008235634A JP2010063441A (en) 2008-09-12 2008-09-12 Methods for removing fat and treating living tissue

Publications (1)

Publication Number Publication Date
JP2010063441A true JP2010063441A (en) 2010-03-25

Family

ID=42189605

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008235634A Withdrawn JP2010063441A (en) 2008-09-12 2008-09-12 Methods for removing fat and treating living tissue

Country Status (1)

Country Link
JP (1) JP2010063441A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012506430A (en) * 2008-10-21 2012-03-15 ザ ジェネラル ホスピタル コーポレイション Cell transplantation
JP2013526868A (en) * 2010-05-20 2013-06-27 リポジェムズ インターナショナル ソシエタ ア レスポンサビリタ リミタータ Apparatus and method for preparing tissue for transplantation, in particular adipose tissue, from leaflet fat extracted by liposuction
US10184110B2 (en) 2010-08-06 2019-01-22 The General Hospital Corporation System and apparatus for cell treatment

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012506430A (en) * 2008-10-21 2012-03-15 ザ ジェネラル ホスピタル コーポレイション Cell transplantation
JP2016185962A (en) * 2008-10-21 2016-10-27 ザ ジェネラル ホスピタル コーポレイション Cell transplantation
US9730963B2 (en) 2008-10-21 2017-08-15 The General Hospital Corporation Cell transplantation
JP2013526868A (en) * 2010-05-20 2013-06-27 リポジェムズ インターナショナル ソシエタ ア レスポンサビリタ リミタータ Apparatus and method for preparing tissue for transplantation, in particular adipose tissue, from leaflet fat extracted by liposuction
JP2016136956A (en) * 2010-05-20 2016-08-04 リポジェムズ インターナショナル ソシエタ ペル アチオニ Apparatus and method for preparing tissue for transplant from lobular fat extracted by liposuction, particularly lipid tissue
JP2018027086A (en) * 2010-05-20 2018-02-22 リポジェムズ インターナショナル ソシエタ ペル アチオニ Device and method for preparing tissue, particularly adipose tissue, for transplantation from lobular fat extracted by liposuction
US10286177B2 (en) 2010-05-20 2019-05-14 Lipogems International S.P.A. Device and kit for preparing tissue, particularly adipose tissue, for transplantation from lobular fat extracted by liposuction
US10286178B2 (en) 2010-05-20 2019-05-14 Lipogems International S.P.A. Method for preparing tissue, particularly adipose tissue, for transplantation from lobular fat extracted by liposuction
US10478587B2 (en) 2010-05-20 2019-11-19 Lipogems International S.P.A. Device and method for preparing tissue, particularly adipose tissue
US11389616B2 (en) 2010-05-20 2022-07-19 Lipogems International S.P.A. Method for preparing tissue, particularly adipose tissue, for transplantation from lobular fat extracted by liposuction
US10184110B2 (en) 2010-08-06 2019-01-22 The General Hospital Corporation System and apparatus for cell treatment

Similar Documents

Publication Publication Date Title
JP2937746B2 (en) Oil and fat refining method
CN1234447C (en) Method and apparatus for isolation of ionic species by electrodialysis
CN1282745C (en) Isolation of microbial oils
CN102517348A (en) Method for preparing 1,3-diglyceride from surface active magnetic nanoparticle immobilized lipase
Agarwal et al. Biofilm detachment by self-collapsing air microbubbles: a potential chemical-free cleaning technology for membrane biofouling
JP6850609B2 (en) Biological reaction device equipped with a device for supplying micro-nano bubbles containing oxygen and micro-nano bubbles containing a bactericidal gas such as ozone.
ES2337530T3 (en) INSULATION OF CAROTENOID CRYSTALS FROM MICROBIAL BIOMASS.
HU227760B1 (en) Vegetable oil enzymatic degumming process by means of aspergillus phospholipase
JP2010063441A (en) Methods for removing fat and treating living tissue
JP2007105081A (en) Cell removal processing of viable tissue for transplantation by supercritical carbon dioxide
WO2014064942A1 (en) Method for treating ballast water and device for treating ballast water used therefor
Ha et al. Enhanced production of fructose palmitate by lipase-catalyzed esterification in ionic liquids
CN104073380A (en) Multi-enzyme cleaner suitable for endoscope cleaning and preparation method thereof
CN1208450C (en) Method for the purification, recovery, and sporulation of cysts and oocysts
KR101035716B1 (en) The recovering method of a low molecular weight sericin from silk degumming process
CN105154253A (en) Biological multienzyme cleaning agent and preparation method thereof
RU2731726C2 (en) Method for obtaining from yeast cells of at least one or more beta-glucan compounds or suspension of solid substances containing beta-glucan
JP3882512B2 (en) Wastewater treatment method
CN1930191A (en) Process for producing deproteinized natural rubber latex
KR102416674B1 (en) Method of Extracting alkali-soluble alginate from Brown Seaweed by using surfactant-treatment
JP2010178695A (en) Device for treating biological tissue
CN103451048A (en) Detergent composition for oil sludge and detergent method using that
Venugopal Wastewater from Pharmaceutical Industry
JP2007268379A (en) Membrane treatment method of balast water
WO1990015137A1 (en) Enzymes immobilised on microporous composite membranes, activated supports prepared therewith, and uses thereof

Legal Events

Date Code Title Description
A300 Withdrawal of application because of no request for examination

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20111206